Back

The impact of desmosomal mutations on clinical features in arrhythmogenic cardiomyopathy: towards tailored arrhythmic risk stratification

1 September 2025 (08:15 - 08:25)
Organised by: Logo
Congress Presentation Part of: Improved understanding of the genetic background of cardiomyopathy Arrhythmogenic Right Ventricular Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marika Martini

University of Padua, Padova (Italy)

5 More presentations in this session

Presentation thumbnail
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies for gene discovery
Ms D. Kramarenko (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Predictors of the identification of clinically relevant genetic variants in dilated cardiomyopathy in a sample of the brazilian population
Mr L. Cedro (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Identification of ultra-rare variants in dilated cardiomyopathy: insights into LMNA pathogenesis and prognostic significance
Doctor T. Kitai (Suita, JP)
Abstract Slides
Presentation thumbnail
Gain-of-function vs. loss-of-function effects of DES variants on cardiodesminopathy phenotypes
Mr M. Urtis (Pavia, IT)
Abstract Slides
Presentation thumbnail
The clinical spectrum of TTN variants in families affected by dilated cardiomyopathy: evidence for a pre-clinical phenotype
Doctor F. Goldie (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Improved understanding of the genetic background of cardiomyopathy
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of the identification of clinically relevant genetic variants in dilated cardiomyopathy in a sample of the brazilian population
thumbnail
Congress Session
Ventricular arrhythmias and sudden cardiac death in cardiomyopathies
thumbnail
Congress Presentation
Redefining genotype-phenotype correlation among patients with arrhythmogenic cardiomyopathy: a CMR cohort study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources